久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Giving world's COVID-19 fight the invaluable benefit of TCM

By Zheng Yiran in Beijing and Zhang Yu in Shijiazhuang | China Daily | Updated: 2020-06-08 09:54
Share
Share - WeChat
Medical professionals hand out Lianhuaqingwen capsules to patients at a Fangcang Hospital in Wuhan, Central China's Hubei province in February. [Photo provided to chinadaily.com.cn]

Yiling Pharma's products get overseas health bodies' nods for market access

As the COVID-19 epidemic situation worsened overseas, Koh Chok Tong, a 35-year-old engineer in Singapore, felt he was lucky enough to be able to buy Lianhuaqingwen capsules manufactured by Shijiazhuang, Hebei province-based Chinese drug firm Yiling Pharmaceutical at a local pharmacy.

Yiling Pharma makes the herbal compound using the traditional Chinese medicine, or TCM, system. The capsules are considered effective in China against the novel coronavirus.

Koh said: "The epidemic situation in Singapore has been volatile in May. On May 10, there were 876 newly confirmed cases. The figure then dropped to 486 the next day. Then, on May 12, the figure went up again to 884.

"Having heard that TCM is effective in preventing and treating COVID-19, my family and I had long been thinking of getting some capsules. Initially, it was hard to buy TCM products in Singapore. Now, to our delight, Lianhuaqingwen capsules are available at local pharmacies. I bought some for my family."

Clinical observations at designated COVID-19 hospitals in China showed that a treatment combining Western medicine and TCM, including Lianhuaqingwen capsules, was effective in the treatment of COVID-19 cases.

Yiling Pharma announced in May its Lianhuaqingwen capsules had been officially listed as Chinese proprietary medicine to treat influenza by the Healthy Sciences Authority of Singapore, which meant the Chinese medicine has been granted local market access.

By now, Lianhuaqingwen has been approved for sale in eight countries outside China. They are Canada, Indonesia, Mozambique, Brazil, Romania, Thailand, Ecuador, and Singapore. It was also granted market access in Hong Kong and Macao.

Wu Rui, board director and secretary of the board of Yiling Pharma, said the international journey of Lianhuaqingwen capsules started years ago.

"To testify the effectiveness of Lianhuaqingwen capsules in the overseas markets, the company had been working with a batch of international medical and scientific research institutions on the experimental study of the medicine for many years," she said.

In September 2016, the phase-II studies for Lianhuaqingwen were approved by the United States Food and Drug Administration and officially started, marking China's first TCM product to enter the FDA's clinical research. It was also the first TCM complex compound in the world to enter the FDA's clinical research.

"In recent years, as TCM was having a constantly increasing influence over the international markets, and the foreigners' acceptance levels of TCM rose, we launched the registration of Lianhuaqingwen capsules in some countries," Wu said.

According to the company, currently, the influenza case collection of the phase-II studies of Lianhuaqingwen capsules in the US has been completed, and its registration in countries and regions in the Middle East, Africa, and Latin America has started.

Wu noted that the biggest obstacle for TCM going global is the cultural differences between East and West. Such gaps cause difficulty for Western countries in knowing more about and understanding TCM.

"Besides, each country and region have their own laws and regulations for drug registration and approval, and the differences hinder TCM from getting market access and becoming popular in overseas markets," she said.

Zhang Boli, an academician at the Chinese Academy of Engineering, said the major problem in internationalizing TCM lies in legislation, as introducing TCM into local markets requires a country to amend its own codes, which is very difficult. Therefore, currently, many TCM products are exported overseas merely as nutrition supplements.

"The fact that Lianhuaqingwen capsules acquired overseas market access represented a major industry breakthrough," he said.

"The wide application and significant clinical efficacy of TCM products in the fight against COVID-19 have raised their international acceptance, further opening the door for TCM to go global," Wu said.

In the COVID-19 epidemic treatment plan issued by the National Health Commission, Lianhuaqingwen capsules were the most frequently mentioned proprietary Chinese medicine, recommended by the fourth, fifth, sixth and seventh edition of the treatment plan.

The study of the effectiveness of Lianhuaqingwen capsules in treating influenza had won the second prize in the National Award for Progress in Science and Technology in 2011, demonstrating its advantage in research and development.

On May 8, the study "Efficacy and Safety of Lianhuaqingwen Capsules, a Repurposed Chinese Herb, in Patients with Coronavirus Disease 2019" was published in the European medicine journal Phytomedicine, pointing out that in light of the safety and effectiveness profiles, the TCM capsules could be considered to ameliorate clinical symptoms of COVID-19. The journal is recognized as an authoritative periodical in the international plant medicine field.

Zhang said problems such as insufficient innovation and low-level duplication were the main reasons behind the difficulties in TCM internationalization, and that a scientific TCM standard that conforms to international standards needs to be established as soon as possible.

Yiling Pharma said it will continue to explore the innovative development path of TCM internationalization. It will give full play to the company's R&D and manufacturing advantages, keep innovating, accelerate the process of TCM modernization, industrialization and internationalization, to contribute to the high-quality development of TCM.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 国产成人18黄网站免费 | 免费视频一区二区 | 久草草视频在线观看免费高清 | 免费人成黄页在线观看视频国产 | 精品久久久久久国产免费了 | 久久香蕉精品视频 | 国产精品国产精品 | 可以免费看黄色的网站 | 爱啪网亚洲第一福利网站 | 久久国产精品自线拍免费 | 国产一区二区三区在线观看免费 | 亚洲欧美在线观看视频 | 美女午夜影院 | 香港国产特级一级毛片 | 亚洲精品成人在线 | 欧美成人性色生活片免费在线观看 | 不卡一级毛片免费高清 | 洋老外米糕国产一区二区 | 国内在线播放 | 中文字幕亚洲 综合久久 | 青草青99久久99九九99九九九 | 国模偷拍在线观看免费视频 | 国产精品视频免费播放 | 九九精品视频一区在线 | 中文字幕视频网站 | 美女被拍拍拍拍拍拍拍拍 | 亚洲永久中文字幕在线 | 成人在线免费视频播放 | 九一精品 | 欧美三级久久 | 久久黄网站 | 精品欧美高清不卡在线 | 在线高清免费爱做网 | 国产精品成人免费视频 | 一级黄色录像片 | 成年免费a级毛片 | 欧美午夜在线观看理论片 | 欧美va免费大片 | 国产精品久久久久久久久久久搜索 | 日本欧美韩国一区二区三区 | 亚洲欧美日韩高清在线看 |